ID
34745
Beskrivning
Study ID: 101998 Clinical Study ID: 101998 Study Title: A randomized, double-blind, parallel group, placebo-controlled, single-attack evaluation of the efficacy and tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg)* tablets vs placebo when administered during the mild pain phase of a migraine Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier Sponsor GlaxoSmithKline Collaborators N/A Phase Phase 3 Study Recruitment Status Completed Generic Name sumatriptan Trade Name Imitrex ,Imiject ,Imigran Study Indication Migraine Disorders This form contains the conclusion of the study it should be filled out at the final visit.
Nyckelord
Versioner (2)
- 26/01/2019 26/01/2019 -
- 01/02/2019 01/02/2019 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
26 janvier 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Efficacy and Tolerability of TREXIMA Tablets vs. Placebo During Mild Migraine Study ID 101998
Study Conclusion
- StudyEvent: ODM
Beskrivning
Study Conclusion
Alias
- UMLS CUI-1
- C1707478 (Conclusion)
- UMLS CUI-2
- C0008972 (Clinical Research)
Beskrivning
If Yes, tick the primary reason for withdrawal
Datatyp
text
Alias
- UMLS CUI [1]
- C0422727 (Patient withdrawn from trial)
- SNOMED
- 185924006
Beskrivning
Adverse Event: Record details on the Non-Serious Adverse Events or Serious Adverse Event pages as appropriate. If subject did not meet treatment eligibility criteria, ensure ’Clinically significant screening lab values’ and/or ’Clinically significant screening ECG abnormalities’ are ticked.
Datatyp
text
Alias
- UMLS CUI [1,1]
- C2349954 (Withdraw (activity))
- UMLS CUI [1,2]
- C0392360 (Indication of (contextual qualifier))
- SNOMED
- 230165009
- LOINC
- MTHU008319
- UMLS CUI [1,3]
- C0008976 (Clinical Trials)
- SNOMED
- 110465008
- LOINC
- LP231796-6
Beskrivning
Other Specification
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0205394 (Other)
- SNOMED
- 74964007
- LOINC
- LP21049-9
- UMLS CUI [1,2]
- C2348235 (Specification)
- UMLS CUI [2,1]
- C2349954 (Withdraw (activity))
- UMLS CUI [2,2]
- C0392360 (Indication of (contextual qualifier))
- SNOMED
- 230165009
- LOINC
- MTHU008319
- UMLS CUI [2,3]
- C0008976 (Clinical Trials)
- SNOMED
- 110465008
- LOINC
- LP231796-6
Beskrivning
Investigator Comment Log
Alias
- UMLS CUI-1
- C0008961 (Clinical Investigators)
- UMLS CUI-2
- C0947611 (Comment)
- LOINC
- LP72293-1
Beskrivning
CRF Page Number
Datatyp
text
Alias
- UMLS CUI [1,1]
- C1704732 (Page (document))
- UMLS CUI [1,2]
- C1516308 (Case Report Form)
Beskrivning
Only use this form to record explanatory information on anomalies such as missing data, sponsor waiver of inclusion/exclusion criteria, departures from planned investigational product administration or missed visits.
Datatyp
text
Alias
- UMLS CUI [1]
- C0947611 (Comment)
- LOINC
- LP72293-1
Beskrivning
Signature
Alias
- UMLS CUI-1
- C1519316 (Signature)
- LOINC
- LP248948-4
Beskrivning
The Investigator is accountable for CRF data. However, the Principal Investigator may delegate CRF signature authority to a medically qualified Sub-investigator (as indicated on the Site Staff Signature Sheet).
Datatyp
text
Alias
- UMLS CUI [1]
- C2346576 (Investigator Signature)
Beskrivning
Date
Datatyp
date
Alias
- UMLS CUI [1]
- C0011008 (Date in time)
- SNOMED
- 410671006
Beskrivning
Investigator's Name
Datatyp
text
Alias
- UMLS CUI [1]
- C2826892 (Investigator Name)
Similar models
Study Conclusion
- StudyEvent: ODM
C0011008 (UMLS CUI [2,1])
C0422727 (UMLS CUI [2,2])
C0392360 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,2])
C2349954 (UMLS CUI [2,1])
C0392360 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C0947611 (UMLS CUI-2)
C1516308 (UMLS CUI [1,2])
Inga kommentarer